Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul;9(1):10-15.
doi: 10.15420/ecr.2014.9.1.10.

The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease

Sven M Francque  1
Affiliations
Review

The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease

Sven M Francque. Eur Cardiol. 2014 Jul.

Abstract

Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver disease in western countries and is closely related to the metabolic syndrome. When NAFLD is associated with hepatocellular damage and inflammation (non-alcoholic steatohepatitis [NASH]) it can lead to severe liver disease. However, it has become clear that NAFLD is also associated with an increased risk of cardiovascular disease (CVD), independently of classical known risk factors for the latter. In the current review we briefly summarise the current clinical evidence on the role of NAFLD in CVD and discuss the potential mechanisms by which NAFLD can be linked to the pathophysiology of CVD.

Keywords: cardiovascular events; non-alcoholic fatty liver disease; pathophysiology; steatosis.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The author has no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Schematic Overview of the Mechanisms that may Link Indirectly or Directly the Liver Affected by Non-alcoholic Fatty Liver Disease to Alterations in the Cardiovascular System
See this image and copyright information in PMC

References

    1. Francque S. van Damme P, Van Herck K, Michielsen P . Chronic hepatitis and liver disease, Oxford Textbook of Public Health. 5th edition. Oxford: Oxford University Press; 2009. Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH). pp. 1249–63.
    1. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Aliment Pharmacol Ther. 2011;34(3):274–85. - PubMed
    1. Verrijken A, Francque S, Van Gaal L. The metabolic syndrome and the liver, Acta Gastroenterol Belg. 2008;71(1):48–59. - PubMed
    1. Brunt EM, Janney CG, Di Bisceglie AM et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, Am J Gastroenterol. 1999;94(9):2467–74. - PubMed
    1. Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol. 2013;10(6):330–44. - PubMed

LinkOut - more resources